Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. C. dos Santos
Efficacy of Benfluorex in Combination With Sulfonylurea in Type 2 Diabetic Patients: An 18-Week, Randomized, Double-Blind Study
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Related publications
A One-Year Multicentre, International, Randomised, Double-Blind Study With Comparison of Benfluorex Versus an Oral Anti-Diabetic in Combination With Sulfonylurea Administered Orally for the Treatment of Type Two Diabetes
Efficacy of Fixed-Dose Amlodipine and Losartan Combination Compared With Amlodipine Monotherapy in Stage 2 Hypertension: A Randomized, Double Blind, Multicenter Study
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus
Global Journal of Endocrinological Metabolism
Propolis Supplementation Improves Glycemic and Antioxidant Status in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study
Complementary Therapies in Medicine
Alternative Medicine
Manual Therapy
Specialized Nursing
Advanced
Complementary
Rosiglitazone in Combination With Glimepiride Plus Metformin in Type 2 Diabetic Patients
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Anti-Hyperglycemic and Anti-Hyperlipidemic Effects of Lupinus Albus in Type 2 Diabetic Patients: A Randomized Double-Blind, Placebo-Controlled Clinical Trial
International Journal of Pharmacology
Pharmacology
Transglucosidase Improves the Bowel Movements in Type 2 Diabetes Mellitus Patients: A Preliminary Randomized Double-Blind, Placebo-Controlled Study
United European Gastroenterology Journal
Oncology
Gastroenterology
The Effect of Aggressive Versus Standard Lipid Lowering by Atorvastatin on Diabetic Dyslipidemia: The DALI Study: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Type 2 Diabetes and Diabetic Dyslipidemia
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes